Defining outcomes for β-cell replacement therapy in the treatment of diabetes

MLA

Peter A. Senior, et al. “Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes.” Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 31, no. 4, Apr. 2018, pp. 343–52. EBSCOhost, https://doi.org/10.1111/tri.13138.

APA

Peter A. Senior, Marie-Christine Vantyghem, Lorenzo Piemonti, James Shaw, Esther Latres, Johann Pratschke, François Pattou, Eelco J.P. de Koning, Barbara Ludwig, Paul Johnson, Thierry Berney, Raja Kandaswamy, Rodolfo Alejandro, Roger Lehmann, James F. Markmann, Steven A. White, Thomas W.H. Kay, Robert M. Langer, Jon S. Odorico, … Yogish C. Kudva. (2018). Defining outcomes for β-cell replacement therapy in the treatment of diabetes. Transplant International : Official Journal of the European Society for Organ Transplantation, 31(4), 343–352. https://doi.org/10.1111/tri.13138

Chicago

Peter A. Senior, Marie-Christine Vantyghem, Lorenzo Piemonti, James Shaw, Esther Latres, Johann Pratschke, François Pattou, et al. 2018. “Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes.” Transplant International : Official Journal of the European Society for Organ Transplantation 31 (4): 343–52. doi:10.1111/tri.13138.